Optomed PlcStock Exchange Release8 May 2023 at 13.00, Helsinki Change in Optomed's holding of treasury A total of 3,500 of shares have been subscribed for under the Company's stock option plans 2020A Optomed has used treasury shares for the share subscriptions. The subscribed shares have been delivered to the subscribers on 8 May 2023. The total amount of treasury shares is now 370 066. Optomed Plc Further enquiries Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com Optomed in Brief Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.